Leef BrandsLEEEF -0.06%30 EBIT per Share is $-0.07 as of Mar. 2026. GuruFocus rates LEEEF with a GF Score™ of 30/100 and a GF Value™ of $0.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 808 Drug Manufacturers companies, Leef Brands ranks better than 88.74% on this metric.
Leef Brands's EBIT per Share for the
three
months ended in Mar. 2026 was $0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.07.
During the past 3 years, the average EBIT per Share Growth Rate was 49.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 39.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 20.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Leef Brands's EBIT per Share or its related term are showing as below:
LEEEF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -42.3 Med: 28.7 Max: 64.2
Current: 49.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Leef Brands was 64.20% per year. The lowest was -42.30% per year. And the median was 28.70% per year.
LEEEF's 3-Year EBIT Growth Rate is ranked better than 88.74% of 808
companies
in the Drug Manufacturers industry
Industry Median: 7.65
vs LEEEF: 49.60
Leef Brands's EBIT for the
three
months ended in Mar. 2026 was $0.87 Mil.
Leef Brands (OTCPK:LEEEF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Leef Brands EBIT per Share Related Terms
Leef Brands EBIT per Share Historical Data
* Premium members only.
The historical data trend for Leef Brands's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a EBIT per Share of $-0.07 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Leef Brands and its competitors. According to the industry distribution chart, Leef Brands ranks #91 out of 808 companies in the Drug Manufacturers industry, placing it in the top 11.3%.
Is Leef Brands' EBIT per Share too high?
Leef Brands' current EBIT per Share is $-0.07. Based on the distribution chart, Leef Brands ranks #91 out of 808 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Leef Brands has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #91 out of 808 companies for EBIT per Share. This places Leef Brands in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 7.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.65, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Leef Brands and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current EBIT per Share is $-0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.13, compared to a current price of $0.17 — trading 30.7% above its estimated fair value. The current EBIT per Share is $-0.07. Leef Brands' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Leef Brands (LEEEF), the current EBIT per Share is $-0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.17 is trading 30.7% above its estimated GF Value™ of $0.13.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
EBIT per Share: $-0.07
GF Value™: $0.13 vs. price of $0.17 (30.7% above fair value)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
30GF Score
Get the complete analysis for LEEEF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
